Does Rallies show 13F holders for CVS?

Yes. Rallies tracks hedge fund and 13F ownership data for CVS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CVS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.

CVS (CVS Health) Stock Analysis - Hedge Fund Holdings

CVS Health (CVS) is a publicly traded Healthcare sector company. As of May 20, 2026, CVS trades at $93.11 with a market cap of $122.48B and a P/E ratio of 14.37. CVS moved -0.73% today. Year to date, CVS is +15.99%; over the trailing twelve months it is +46.34%. Its 52-week range spans $43.56 to $98.43. Analyst consensus is strong buy with an average price target of $102.35. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CVS stock?

Hedge funds tracked by Rallies that own CVS include Glenview Capital, Fairfax Financial, Third Point, Bridgewater Associates, and Harris Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CVS Health.

CVS Key Metrics

Key financial metrics for CVS
Metric	Value
Price	$93.11
Market Cap	$122.48B
P/E Ratio	14.37
EPS	$6.49
Dividend Yield	0.67%
52-Week High	$98.43
52-Week Low	$43.56
Volume	6.00M
Avg Volume	0
Revenue (TTM)	$357.78B
Net Income	$8.37B
Gross Margin	39.32%

Top Hedge Funds Holding CVS

Glenview Capital holds 8.20M shares of CVS, changed +0.00% as of Mar 31, 2026.
Fairfax Financial holds 2.71M shares of CVS, changed +0.00% as of Mar 31, 2026.
Third Point holds 1.57M shares of CVS, changed +0.00% as of Sep 30, 2024.
Bridgewater Associates holds 618.43K shares of CVS, changed -40.38% as of Mar 31, 2026.
Harris Associates holds 494.13K shares of CVS, changed -5.89% as of Mar 31, 2026.

Latest CVS News

CVS Health Invests $292M in Veteran-Owned Businesses and Expands Military Family Programs — May 20, 2026
CVS Health invests $20 billion in digital health tools after survey finds 58% of seniors struggle — May 18, 2026
CVS Health, WGU Launch Online Pre-Pharmacy Program with $3,989 Term Tuition — May 14, 2026
MinuteClinic Weight-Loss Program Posts 85% Three-Month Success Across 49 States, Primary Care at 60% of Clinics — May 13, 2026
CVS jumps as TD Cowen lifts price target to $110, keeps buy — May 12, 2026

Recent CVS Insider Trades

Mandadi Tilak sold 69.55K (~$6.23M) on May 8, 2026.
Finucane Anne A. sold 7.50K (~$532.65K) on Aug 20, 2025.
SANSONE GUY P bought 1.57K (~$100.01K) on Jun 5, 2025.

CVS Analyst Consensus

17 analysts cover CVS: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.35.

Common questions about CVS

Who owns CVS stock?: Hedge funds tracked by Rallies that own CVS include Glenview Capital, Fairfax Financial, Third Point, Bridgewater Associates, and Harris Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CVS Health.
Does Rallies show 13F holders for CVS?: Yes. Rallies tracks hedge fund and 13F ownership data for CVS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CVS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.